Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Incidence of amenorrhea (A) in breast cancer (BC) patients (pts) <= 40 years of age after paclitaxel (T)-based adjuvant chemotherapy (CT)
    Meeting Abstract

    Fornier, M. N.; Modi, S.; Hudis, C. A.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save
  • Serum HER2 extracellular domain (ECD) correlates with HER2 status by immunohistochemistry (IHC) and fluorescent in-situ hybridization (FISH) in metastatic breast cancer (MBC) patients (pts) treated with weekly (W) trastuzumab (H) and paclitaxel (T)
    Meeting Abstract

    Fornier, M. N.; Seidman, A. D.; Schwartz, M. K.; Panageas, K. S.; Norton, L.; Hudis, C. A.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save
  • Open-label, phase II, multicenter trial of ZD1839 ('Iressa') in patients with advanced breast cancer
    Meeting Abstract

    Albain, K.; Elledge, R.; Gradishar, W. J.; Hayes, D. F.; Rowinsky, E.; Hudis, C.; Pusztai, L.; Tripathy, D.; Modi, S.; Rubi, S.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save
  • [Commentary on] Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial
    Journal Article

    Robson, M.
    Women's Oncology Review (2002)

    Fulltext@MSK | Save
  • [Commentary on] Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: A randomized trial
    Journal Article

    Dang, C.
    Women's Oncology Review (2002)

    Fulltext@MSK | Save
  • Estrogen receptor-beta expression in hereditary breast cancer - In reply
    Journal Article

    Scheuer, L.; Kauff, N. D.; Robson, M. E.; Offit, K.
    Journal of Clinical Oncology (2002)

    Fulltext@MSK | Save
  • Oophorectomy in carriers of BRCA mutations - Reply
    Journal Article

    Kauff, N. D.; Robson, M. E.; Offit, K.
    New England Journal of Medicine (2002)

    Fulltext@MSK | Save
  • Capecitabine in the treatment of advanced breast cancer
    Journal Article

    Hudis, C.
    Oncology (Norwalk) (2002)

    Fulltext@MSK | Save
  • Cardiac dysfunction in clinical trials of trastuzumab - Reply
    Journal Article

    Seidman, A. D.; Pierri, M. K.; Hudis, C.
    Journal of Clinical Oncology (2002)

    Fulltext@MSK | Save
  • The Williams article reviewed [Is there a role for dose-intensive chemotherapy with stem cell rescue in breast cancer?]
    Journal Article

    Hudis, C.
    Oncology (Norwalk) (2002)

    Fulltext@MSK | Save